Physician profile
Joseph P Mizzell
NPI 1356480347
$1,921.86
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $778 · 2020: $351 · 2021: $591 · 2022: $201.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $370.51 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $343.78 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $174.12 | 2019-2020 | |
| Advanced Respiratory, INC | $167.07 | 2019-2021 | |
| Glaxosmithkline, LLC. | $130.89 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $113.92 | 2019-2021 | |
| Pfizer INC. | $111.01 | 2019-2020 | |
| Teleflex LLC | $76.99 | 2021 | |
| Insmed, INC. | $72.88 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $68.82 | 2019-2021 | |
| Philips North America LLC | $60.45 | 2019-2021 | |
| Electromed, INC. | $59.00 | 2019-2021 | |
| Mylan Specialty L.P. | $36.64 | 2019 | |
| Shire North American Group INC | $30.94 | 2019 | |
| Sanofi Pasteur INC. | $18.81 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $18.22 | 2019 | |
| Cook Medical LLC | $17.57 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.53 | 2019 | |
| Amgen INC. | $17.17 | 2020 | |
| Paratek Pharmaceuticals, INC. | $15.54 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mizzell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.